γ-Adrenergic Blockade Accelerates Conversion of Postoperative Supraventricular Tachyarrhythmias
- 1 November 1998
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 89 (5) , 1052-1059
- https://doi.org/10.1097/00000542-199811000-00004
Abstract
Background: Postoperative supraventricular tachyarrhythmia is a common complication of surgery. Because chemical cardioversion is often ineffective, ventricular rate control remains a principal goal of therapy. The authors hypothesized that patients with supraventricular tachyarrhythmia after major noncardiac surgery who receive intravenous beta-adrenergic blockade for ventricular rate control would experience conversion to sinus rhythm at a rate that differs from those receiving intravenous calcium channel blockade. Methods: The rate of conversion to sinus rhythm at 2 and 12 h after treatment was examined in 64 cases of postoperative supraventricular tachyarrhythmia. After adenosine administration, patients who remained in supraventricular tachyarrhythmia were prospectively randomized to receive either intravenous diltiazem or intravenous esmolol for ventricular rate control (unblinded). Loading and infusion rates were adjusted to achieve equivalent degrees of ventricular rate control. Results: Patients were similar with regard to age and Apache III score. Most patients in both groups had atrial fibrillation (esmolol, 79%; diltiazem, 81%), and none experienced stable conversion with adenosine. Patients randomized to receive esmolol experienced a 59% rate of conversion to sinus rhythm within 2 h of treatment, compared with only 33% for patients randomized to receive diltiazem (intention to treat, P = 0.049; odds ratio, 2.9; 95% confidence interval, 1.046 to 7.8). After 12 h of therapy, the number of patients converting to sinus rhythm increased in both groups (esmolol, 85%; diltiazem, 62%), and the rates of conversion no longer differed significantly. Ventricular rates when supraventricular tachyarrhythmia began and after 2 and 12 h of rate control therapy were similar in the two treatment groups. The in-hospital mortality rate and length of stay in the intensive care unit were not significantly influenced by treatment group. Conclusions: Among adenosine-resistant patients in the intensive care unit with atrial fibrillation after noncardiac surgery, intravenous esmolol produced a more rapid (2-h) conversion to sinus rhythm than did intravenous diltiazem.Keywords
This publication has 33 references indexed in Scilit:
- Magnesium therapy in new-onset atrial fibrillationThe American Journal of Cardiology, 1994
- Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass graftingCritical Care Medicine, 1993
- Postoperative atrial fibrillation in cancer surgery: Preoperative risks and clinical outcomeJournal of Surgical Oncology, 1992
- Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass graftingThe American Journal of Cardiology, 1992
- Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass graftingThe American Journal of Cardiology, 1991
- Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular systemAmerican Heart Journal, 1991
- Epidural morphine decreases postoperative hypertension by attenuating sympathetic nervous system hyperactivityJAMA, 1989
- Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1989
- Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillationThe American Journal of Cardiology, 1988
- Use of calcium antagonists for cardiac arrhythmiasThe American Journal of Cardiology, 1987